Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Supermag B6 is an oral nutritional supplement developed by Penta Pharma, combining magnesium and vitamin B6 (pyridoxine). Magnesium is a vital mineral that serves as a cofactor for over 300 biochemical reactions in the body, including those involved in energy metabolism, protein synthesis, and muscle and nerve function. Vitamin B6 (pyridoxine) is included to enhance the intestinal absorption of magnesium and its entry into cells, while also acting as a coenzyme in the metabolism of amino acids, lipids, and carbohydrates. This product is typically indicated for the prevention and treatment of magnesium deficiency and associated symptoms such as muscle cramps, fatigue, and irritability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on magnesium + pyridoxine (Penta Pharma).